Squarepoint’s Immune Design Corp. IMDZ Stock Holding History

Squarepoint’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,111	Closed	-$46K	–	2396
2018 Q2	$46K	Buy	+10,111	New	+$40.3K	﹤0.01%	1694
2018 Q1	–	Sell	-36,250	Closed	-$141K	–	2503
2017 Q4	$141K	Buy	+36,250	New	+$197K	﹤0.01%	1887
2017 Q3	–	Sell	-13,500	Closed	-$132K	–	2073
2017 Q2	$132K	Sell	13,500 -9,483	-41%	-$66.5K	﹤0.01%	1376
2017 Q1	$156K	Buy	22,983 +7,941	+53%	+$45.9K	﹤0.01%	1342
2016 Q4	$83K	Buy	+15,042	New	+$106K	﹤0.01%	1653

Other funds holding IMDZ

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's IMDZ Position: Q3 2018 in Review

Squarepoint sold out of Immune Design Corp. (IMDZ) in Q3 2018, closing a stake of 10,111 shares — an estimated $46K sold.

Squarepoint first reported a position in IMDZ in Q4 2016 and held it in 5 quarters. The position peaked at $156K in Q1 2017. 71 funds tracked by Wall St. Rank hold IMDZ as of Q3 2018.

Squarepoint reported no remaining Immune Design Corp. position as of Q3 2018 after selling out during the quarter.
Squarepoint sold 10,111 Immune Design Corp. shares in Q3 2018, an estimated $46K.
Squarepoint first reported a position in Immune Design Corp. in Q4 2016 and held it in 5 quarters.
Squarepoint's Immune Design Corp. position peaked at $156K in Q1 2017.
71 funds tracked by Wall St. Rank held Immune Design Corp. as of Q3 2018.

Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.